Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats

Journal of Controlled Release

Volumn 172, Issue 3, 2013, Pages 872-878

  Gradauer, K ^a   Barthelmes, J ^b   Vonach, C ^a   Almer, G ^a   Mangge, H ^a   Teubl, B ^c   Roblegg, E ^c   Dunnhaupt S ^b   Frohlich E ^a   Bernkop Schnurch A ^b   Prassl, R ^a,d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Chitosan; Liposome; Permeation enhancement; Salmon calcitonin; Thiomer

Indexed keywords

NEGATIVE CONTROL; ORAL BIOAVAILABILITIES; ORAL PEPTIDE DELIVERY; PERMEATION ENHANCEMENT; SALMON CALCITONIN; SMALL INTESTINE; THIOLATED CHITOSAN; THIOMER;

BIOCHEMISTRY; BLOOD; CALCIUM; CHITOSAN; PEPTIDES; PLASTIC COATINGS; RAT CONTROL; RATS;

LIPOSOMES;

CALCIUM; CHITOSAN; LIPOSOME; SALCATONIN; THIOGLYCOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG STRUCTURE; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MALE; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; STATIC ELECTRICITY; ZETA POTENTIAL;

CHITOSAN; LIPOSOME; PERMEATION ENHANCEMENT; SALMON CALCITONIN; THIOMER;

ADMINISTRATION, ORAL; ANIMALS; CALCITONIN; CHITOSAN; INTESTINE, SMALL; LIPOSOMES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS;

EID: 84887204356     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.10.011     Document Type: Article

References (35)

1. IMARC Global Biopharmaceutical Market Report (2010-2015) 2013 IMARC
2. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.O. Quinkert, F. Martin, and C. Muller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 2010 1469 1486
3. D. Shukla, S. Chakraborty, S. Singh, and B. Mishra Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications Expert Opin. Drug Deliv. 8 2011 207 224
4. L.M. Ensign, R. Cone, and J. Hanes Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers Adv. Drug Deliv. Rev. 64 2012 557 570
5. M. Elsabahy, and K.L. Wooley Design of polymeric nanoparticles for biomedical delivery applications Chem. Soc. Rev. 41 2012 2545 2561
6. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 2000 429 442
7. B.J. Aungst Absorption enhancers: applications and advances AAPS J. 14 2012 10 18
8. K. Park, I.C. Kwon, and K. Park Oral protein delivery: current status and future prospect React. Funct. Polym. 71 2011 280 287
9. D.J. Brayden, and R.J. Mrsny Oral peptide delivery: prioritizing the leading technologies Ther. Deliv. 2 2011 1567 1573
10. K. Gradauer, C. Vonach, G. Leitinger, D. Kolb, E. Frohlich, E. Roblegg, A. Bernkop-Schnurch, and R. Prassl Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties Int. J. Nanomedicine 7 2012 2523 2534
11. K. Gradauer, S. Dunnhaupt, C. Vonach, H. Szollosi, I. Pali-Scholl, H. Mangge, E. Jensen-Jarolim, A. Bernkop-Schnurch, and R. Prassl Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties J. Control. Release 165 2013 207 215
12. M. Azria, D.H. Copp, and J.M. Zanelli 25 years of salmon calcitonin: from synthesis to therapeutic use Calcif. Tissue Int. 57 1995 405 408
13. C.H. Chesnut III, M. Azria, S. Silverman, M. Engelhardt, M. Olson, and L. Mindeholm Salmon calcitonin: a review of current and future therapeutic indications Osteoporos. Int. 19 2008 479 491
14. E. Frohlich, C. Samberger, T. Kueznik, M. Absenger, E. Roblegg, A. Zimmer, and T.R. Pieber Cytotoxicity of nanoparticles independent from oxidative stress J. Toxicol. Sci. 34 2009 363 375
15. E.E. Hassan, and J.M. Gallo A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength Pharm. Res. 7 1990 491 495
16. V.V. Khutoryanskiy Advances in mucoadhesion and mucoadhesive polymers Macromol. Biosci. 11 2011 748 764
17. A.W. Larhed, P. Artursson, J. Grasjo, and E. Bjork Diffusion of drugs in native and purified gastrointestinal mucus J. Pharm. Sci. 86 1997 660 665
18. J.S. Crater, and R.L. Carrier Barrier properties of gastrointestinal mucus to nanoparticle transport Macromol. Biosci. 10 2010 1473 1483
19. T.T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 16 1995 351 380
20. M. Dawson, D. Wirtz, and J. Hanes Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport J. Biol. Chem. 278 2003 50393 50401
21. G. Aljayyoussi, M. Abdulkarim, P. Griffiths, and M. Gumbleton Pharmaceutical nanoparticles and the mucin biopolymer barrier Bioimpacts 2 2012 173 174
22. R.A. Cone Barrier properties of mucus Adv. Drug Deliv. Rev. 61 2009 75 85
23. Y.Y. Wang, S.K. Lai, C. So, C. Schneider, R. Cone, and J. Hanes Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure PLoS One 6 2011 e21547
24. S.K. Lai, Y.Y. Wang, D. Wirtz, and J. Hanes Micro- and macrorheology of mucus Adv. Drug Deliv. Rev. 61 2009 86 100
25. A.E. Clausen, and A. Bernkop-Schnurch Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs Eur. J. Pharm. Biopharm. 51 2001 25 32
26. A.E. Clausen, C.E. Kast, and A. Bernkop-Schnurch The role of glutathione in the permeation enhancing effect of thiolated polymers Pharm. Res. 19 2002 602 608
27. M. Werle, and M. Hoffer Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine J. Control. Release 111 2006 41 46
28. F. Foger, K. Kafedjiiski, H. Hoyer, B. Loretz, and A. Bernkop-Schnurch Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan J. Drug Target. 15 2007 132 139
29. S. Dunnhaupt, J. Barthelmes, D. Rahmat, K. Leithner, C.C. Thurner, H. Friedl, and A. Bernkop-Schnurch S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties Mol. Pharm. 9 2012 1331 1341
30. D. Guggi, C.E. Kast, and A. Bernkop-Schnurch In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix Pharm. Res. 20 2003 1989 1994
31. W. Cheng, S. Satyanarayanajois, and L.Y. Lim Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity Pharm. Res. 24 2007 99 110
32. S. Dunnhaupt, J. Barthelmes, J. Iqbal, G. Perera, C.C. Thurner, H. Friedl, and A. Bernkop-Schnurch In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan J. Control. Release 160 2012 477 485
33. M. Werle, A. Makhlof, and H. Takeuchi Carbopol-lectin conjugate coated liposomes for oral peptide delivery Chem. Pharm. Bull. (Tokyo) 58 2010 432 434
34. M. Cetin, Y.S. Youn, Y. Capan, and K.C. Lee Preparation and characterization of salmon calcitonin-biotin conjugates AAPS PharmSciTech 9 2008 1191 1197
35. H. Takeuchi, Y. Matsui, H. Yamamoto, and Y. Kawashima Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats J. Control. Release 86 2003 235 242